Tauriga Sciences, Inc. Teams Up with No Excuses Enterprises, LLC and its Founder, NFL Hall of Famer Ray Lewis, to Leverage Additional Market Opportunities
The Initial Focus of this Partnership will be Aimed at the World of Professional Sports NEW YORK, NY, June 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), more...
Aptevo Therapeutics’ Scientists to Present At Virtual Cell Engager Summit
SEATTLE, WA / ACCESSWIRE / June 30, 2021 / Aptevo Therapeutics Inc. (“Aptevo”) (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced more...
Journey Medical Corporation Enters into a Definitive Agreement with Dr. Reddy’s Laboratories Ltd. to Develop and Commercialize DFD-29 for the Treatment of Rosacea
Journey Medical and Dr. Reddy’s Laboratories Ltd. will conduct two Phase 3 clinical trials to assess the efficacy, safety and tolerability of oral minocycline for regulatory approval NEW YORK and SCOTTSDALE, Ariz., June 30, 2021 more...
Cidara Therapeutics to Present New Analyses for Rezafungin at the 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today more...
Harborside Inc. Announces Completion of Salinas Cultivation Facility Upgrades
Harborside Inc. Announces Completion of Salinas Cultivation Facility Upgrades PR Newswire Upgrades Expected to Generate Over 50% Increase in Annual Cultivation Capacity and Enable Year-Round Production Initial Planting Expecting to Commence Week of July 5th more...
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
Trial Dosed Healthy Volunteers with Trans Sodium Crocetinate CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that enhance the more...
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder more...
The Valens Company Enters Agreement to Manufacture Beverages and Edibles for Gallery Brands, a Premier Cannabis Brand House
The Valens Company Enters Agreement to Manufacture Beverages and Edibles for Gallery Brands, a Premier Cannabis Brand House PR Newswire Valens will manufacture cannabis products for two of Gallery’s flagship brands, Blessed and flir KELOWNA, more...
Sugarbud Expands Product Portfolio In Alberta
CALGARY, Alberta, June 30, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT,) (OTCQB: SBUDF) (“Sugarbud” or the “Company”) is pleased to announce the expansion of the Company’s product portfolio more...
Alcanna Announces Acceptance of Normal Course Issuer Bid
EDMONTON, Alberta, June 30, 2021 (GLOBE NEWSWIRE) — Alcanna Inc. (the ” Company ” or ” Alcanna “) (TSX: CLIQ) today reported it has received approval from the Toronto Stock Exchange (the ” TSX “) more...